← Leaderboards
Jasmin Bavarva
Leidos Biomedical Research, Inc.
$4,290,184
Attributed
$4,290,184
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4M · FY2018–24$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,290,184 · 1
By mechanism
N01$3,991,276 · 1
N02$298,908 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Ethan Dmitrovsky$597,515,186
- Lynn Briscoe$495,968,635
- Leonard Freedmand$281,097,701
Others in their field
Other Emerging Leaders on “Genomics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- Scott Topper · Broad Institute, Inc.$153,234,573
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,892,657
- Leonard Freedmand · Leidos Biomedical Research, Inc.$96,686,407
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Scott Andrew Sutherland · Vignet, Inc.$37,105,117
Research focus
GenomicsRefractory CancerMalignant NeoplasmsRefractory
Grant awards (3)
Refractory Cancers Biospecimen Acquisition and Genomic Characterization$40,271
N02 · FY2024 · CA · contact PI
Refractory Cancers Biospecimen Acquisition and Genomic Characterization$258,637
N02 · FY2023 · CA · contact PI
Refractory Cancers Biospecimen Acquisition and Genomic Characterization$3,991,276
N01 · FY2018 · CA · contact PI